(Updated - May 9, 2023 5:00 PM EDT)

Emergent BioSolutions (NYSE: EBS) reported Q1 EPS of ($3.17), versus $0.00 reported last year. Revenue for the quarter came in at $165.1 million versus the consensus estimate of $175.12 million.

For earnings history and earnings-related data on Emergent BioSolutions (EBS) click here.

Earnings